Owner: Rimonabant 2007 URL:http://aznafto.com/ Join Date: Sat, 15 Sep 2007 11:33:42 -0500 Rating:0 Site Description: News and reports about Rimonabant, know about rimonabant acomplia in 2007 Site statistics:Click here
Buy Rimonabant Online, Anti-Obesity Drug’s Claimed Additional Benefits 2007-09-15 16:34:16 Additional beneficial effects on ‘cardiometabolic risk factors’ beyond those expected from weight loss in trials of the anti-obesity drug rimonabant may not be due to the drug itself, reports an article in the June issue of Drug and Therapeutics Bulletin (DTB).
Advertisements for rimonabant (sold under the brand name Acomplia by Sanofi-Aventis) claim that ‘an estimated 50% of the effects … on cardiometabolic risk factors are beyond those expected from weight loss alone’. But DTB argues that these effects are not proven to be due to the drug itself.
Also, no published trials have compared rimonabant with either of the other anti-obesity drugs orlistat or sibutramine. Instead, rimonobant’s effects on weight have been assessed in four double-blind trials comparing the drug with placebo.
The article says: ‘In three of the trial reports, the authors state that the effects of rimonabant on HDL, triglycerides and HBA1c were partly independent of weight lo Read more:Benefits
Acomplia Rimonabant A New Kind of Appetite Suppressant - Hope for the Obese? 2007-09-15 16:33:02 Overweight or obese people who are stout around the waist and abdomen are particularly at high risk for developing type 2 diabetes and high blood pressure. The most effective way to reduce blood pressure and the risk for secondary diseases is to reduce weight. But most patients do not succeed in losing weight and keeping it off. A possible alternative could be an entirely new substance group which simultaneously blocks feelings of hunger and reduces blood lipid levels, thereby reducing the risk for cardiovascular diseases and type 2 diabetes.
The new drug, called Rimonabant, has been tested in clinical trials for over two years in Europe and the USA. The European Director of the clinical trials, Professor Luc Van Gaal of the University Hospital in Antwerp, Belgium, presented results of this study at the 4th International Symposium on Obesity and Hypertension at the Max Delbr�ck Center for Molecular Medicine (MDC) Berlin-Buch on Saturday, October 29, 2005. The meeting, which began on Read more:Obese
Rimonabant Weight-Loss Pill Offers Modest Results, Blocks ‘Munchies’ 2007-09-15 16:31:35 A new drug billed as a magic bullet for obesity - rimonabant (Acomplia) - does help people lose weight, although not that much weight, and also helps lower cardiac risk factors, according to a review of studies.
Rimonabant went on sale in Europe in July, and U.S. approval is pending before the Food and Drug Administration. The drug works in a new way, suppressing the appetite by targeting the brain cells involved in the “munchies” familiar to marijuana users.
“The use of rimonabant after one year produces modest weight loss of approximately 5 percent” of body weight, found reviewers led by Cintia Curioni, at the State University of Rio de Janeiro, in Brazil. “Compared with placebo, a 20-milligram pill produced a 4.9 kilogram greater reduction in body weight in trials with one-year results.”
This translates to weight loss of a little under 11 pounds.
The review looked at four randomized controlled trials comparing rimonabant at two dosages and with pl Read more:Weight
, lsquo
, Modest
, Offers
, Blocks
Buy Rimonabant, a new anti smoking and obesity drug 2007-09-15 16:29:16 Is Rimonabant a new anti smoking drug? Effects of Rimonabant in the Reduction of Major Cardiovascular Risk Factors. Results from the STRATUS-US Trial (Smoking Cessation in Smokers Motivated to Quit and the RIO-LIPIDS Trial (Weight Reducing and Metabolic Effects in Overweight/Obese Patients with Dyslipidemia).
Rimonabant, a selective cannabinoid type 1 receptor blocker, significantly increases smoking cessation rates and reduces weight gain associated with smoking cessation compared to placebo.
Approximately one-third of coronary heart disease is attributable to smoking. Also, because nicotine is an appetite suppressant, many patients are reluctant to stop smoking due to the associated risk of weight gain.
Repeated nicotine use can overstimulate the endocannabinoid system which regulates food intake and energy balance. The purpose of the Phase III STRATUS-US trial was to evaluate the efficacy of rimonabant in restoring balance to the endocannabinoid system, thus, inhibiting nicotine and Read more:obesity
Rimonabant Drug Shows Promise in Helping Obese Patients Lose Weight 2007-09-15 16:22:36 After two years on a drug that affects the pleasure center of the brain, obese patients had reason to feel good: Their bellies shrank, their cholesterol improved and their insulin levels moved toward normal, according to research presented Tuesday in New Orleans.
In the trial, more than 3,000 patients lost an average of 19 pounds, including an important reduction of 3.1 inches on their waistlines, compared with a 5-pound weight loss in the placebo group. Central fat is the kind that is most associated with heart disease risk.
Results of the latest trial of the drug rimonabant, which works on certain receptors in brain cells, were presented at the American Heart Association’s Scientific Sessions. A Milwaukee hospital will be conducting a new clinical trial of the drug beginning next month.
“It could be an exciting new player in obesity,” said Robert Eckel, a physician and professor of physiology at the University of Colorado Health Sciences Center who was not as Read more:Weight
, Helping
, Obese
Rimonabant FDA: Worries about Rimonabant? 2007-09-15 16:19:43 Continuing on the theme of unexpected toxicity landmines, I wanted to take a look at a highly anticipated obesity drug from Sanofi. Rimonabant is a small molecule antagonist of the CB-1 receptor, and it’s been getting a lot of press - both for its impressive efficacy and for its mechanism of action. The “CB” in the receptor name stands for “cannabinoid”, and the drug blocks the same receptor whose stimulation causes the well-known food cravings brought on by marijuana.
Interestingly, blockade of this receptor not only seems to affect appetite, but also seems to help with cravings for nicotine. As you can imagine, the market potential for the drug could be immense (and as you can imagine, other drug companies are chasing the same biological target, too.)
But what else does an antagonist do? The receptor has, no doubt, several functions in the brain (all the CNS receptors do multiple duty), and it’s scattered around in the nerves and other tissues as w
Why Rimonabant Acomplia? 2007-09-15 15:53:28 Rimonabant has been developed from the knowledge that cannabis smokers often experience extreme hunger pangs, which cannabis smokers refer to as ‘the munchies’.
Specifications - Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
Key Data
Drug (brand/generic)
Acomplia / rimonabant
Company/licensee
Sanofi-Aventis
Therapy class
Cannabinoid receptor antagonist
Product description
Selective inhibitor of the CB1 endocannabinoid receptor
Current indication
Treatment of obesity in combination with dietary control
Market sector
Nutrition
Development status
Approved in Europe, pre-registration in the US
Rimonabant Trials, Clinical Studies 2007-09-15 15:50:45 The promising preclinical findings with Acomplia (rimonabant) have been confirmed in a series of clinical studies, including pivotal phase III trials involving over 6,000 obese subjects that were carried out in both the US and Europe.
Two-year data from the phase III multicentre Rimonabant In Obesity (RIO) trials, which compared rimonabant at doses of 5mg and 20mg with placebo with respect to weight reduction and prevention of weight gain, showed that the positive results seen after a year’s treatment were sustained over the full two-year trial period.
“There is a strong association between obesity and increased risk of cardiovascular disease, diabetes and possibly certain cancers.”
Consistent with the one-year data, the results showed that overweight and obese patients taking rimonabant 20mg/d achieved significant reductions in body weight, waist circumference (an indicator of abdominal obesity) and improved lipid and glycaemic profiles compared with placebo recipien Read more:Trials
, Studies
Rimonabant Clinical Trials| THERAPEUTIC APPROACHES TO TREATMENT OF OBESITY 2007-09-15 15:49:19 Not surprisingly, the growing prevalence of obesity has stimulated the search for drugs to treat this condition. Various therapeutic strategies have been explored, including:
Serotonin and noradrenaline reuptake inhibitors (anorectic agents)
Lipase inhibitors
ß 3-adrenoreceptor agonists
Leptin agonists
Melanocortin-3 agonists
Sanofi-Aventis’ approach is completely different to the above. It developed from the knowledge that cannabis smokers often experience extreme hunger pangs, which cannabis smokers refer to as “the munchies”. Sanofi-Aventis worked on the premise that if cannabinoids stimulate appetite, blocking cannabinoid receptors in the brain might reduce appetite.
The central cannabinoid (CB1) receptors are believed to play a role in controlling food consumption and the phenomena of dependence / habituation. To develop suitable drugs against this target, the human cannabinoid receptor was first cloned and then expressed in cells.
Compounds with potential inh Read more:Trials
Rimonabant : Obesity Predisoposes To Serious Iillness 2007-09-15 15:47:53 Obesity is now the most common nutritional disorder in western industrialised countries. Defined as a body mass index of greater than 30, it arises from the accumulation of excess fat in the body from over consumption of fatty foods. Prevalence of obesity in the US and Europe has reached epidemic levels.
Data from the World Health Organisation’s MONICA project show that in some parts of Europe over 70% of men aged 55-64 years are clinically obese or overweight (BMI >25) and almost 70% of women in this age group. One in five of all Americans is obese and one in three overweight. Furthermore, increasing rates of childhood obesity are likely to exacerbate the trend towards increasing obesity in adulthood.
“The central cannabinoid (CB1) receptors are believed to play a role in controlling food consumption.”
There is a strong association between obesity and increased risk of cardiovascular disease and diabetes and possibly certain cancers, such as breast and colorectal can
Acomplia- Your Supreme Answer to Obesity 2007-09-24 12:52:28 When people’s body weight jump off to a sedating point, they not only have to go through lots of embarrassing situations but have to endure the psychological trauma in addition. And the end product is nerve-wrecking frustration and depression. Under such conditions, most people fall prey to strenuous dieting plans in order to shed off those unwanted pounds. Dieting may be a solution to burn extra fat, but at same time, it also brings in several perilous diseases. But it does not mean that there is no credible alternative left to shed off flab devious of any perilous effect. Acomplia is one such plausible option that you can trust without any fret. And you should be grateful to modern medical novelties which made this possible and facilitated us with such wonderful anti-obesity preparation.
Developed by Sanofi-Aventis, the marvel drug enables obese and overweight to control their body weight. Recognized also as rimonabant, acomplia diet pills work with a combination of balanced d Read more:Supreme
Acomplia Rimonabant as a Weight loss drug 2007-09-24 12:48:27 Pill-weight-loss is secured and authentic website where you can order Acomplia (Rimonabant/Zimulti) online for weight loss. Acomplia Rimonabant is a new weight loss drug by Sanofi aventis to fight against obesity. Acomplia Rimonabant (Zimulti) also helps at some extent to quit smoking and for diabetes treament. You can Buy Acomplia Rimonabant from our website for obesity/weight loss treatment.Purchase Acomplia (Rimonabant), the new age weight loss drug which is developed by world’s third largest French pharmaceutical Sanofi-Aventis, to help ever growing number of obese population across the world. Acomplia Rimonabant (Acomplia/Zimulti) is recommend to those patients (BMI = 30 kg/m2), or overweight patients (BMI > 27 kg/m2) with associated risk factors such as type 2 diabetes or dyslipidemia. Rimonabant is sold under the brand name Acomplia in Europe and by the brand name Zimulti in USA. EU Union has approved Acomplia for weight loss treatment but Zimulti is still waiting for the Read more:Weight
Acomplia Rimonabant helps people with type 2 diabetes. 2007-09-21 13:15:42 Acomplia weight loss drug, a new drug that works by affecting the body’s cannabinoid system, appears to also help people
with type 2 diabetes loose pounds, reduce waist size, and even control blood sugar and blood fats, researchers say.
“This is an interesting new class of drugs that probably offers something new and different to people with diabetes,” said Dr. Larry Deeb, president of medicine and science at the American Diabetes Association. He was not involved in the research.
In the study, Andre Scheen, from the University of Liege, Belgium, and colleagues looked at the effects of rimonabant (brand name Acomplia) in over 1,000 patients with poorly controlled type 2 diabetes. All the patients were obese or overweight and had failed treatment with other drugs.
The patients were given a low-calorie diet plan and advised to be more physically active. They were also given rimonabant at a dose of either 5 milligrams or 20 milligrams per day, or a placebo.
After a year,
Treating Obesity with Rimonabant, Aiding Weight Loss 2007-09-21 13:12:46 As we have all discovered Obesity is a serious medical condition. It can lead to many serious health complications. So once we have crossed over to this side of the overweight problem, we have to tread very carefully and treat this condition with determination and courage. The best part is it can be treated.
Our modern pattern of living in a fast paced time zone with the fast cars and high stress levels leads to this condition. More than often we do not even realise what really led to being so overweight and when we do we are already in the condition that requires medical attention.
Obesity can be caused due to: Genetic disposition Wrong Diet No or Limited Exercise Any other Illness Eating Disorders Stress The diseases that arise as a result of being obese or overweight are: Heart disease, high blood pressure, diabetes, high cholesterol, and certain kinds of cancer, osteoarthritis, gastophageal disease, obstructive sleep syndromes, and asthma. Being overweight is actually a sign of im Read more:Weight
Acomplia Diet Pill for drive obesity towards Slimness 2007-09-21 13:11:13 Acomplia diet pill is the true solution for drive
your obesity
towards slimness and smart body shape. As you all know that obesity can pull down your self-confidence, make your life sad, apart from making you a butt of everyone’s jokes. Now this is the time in which you must do something about your obesity. Acomplia diet pill is one of the most sorts out ways to deal with the sprite of obesity. Obesity is not only a health hazard on its own but also tags along many health risks as well like high blood pressure. Henceforth, it is essential to tackle obesity effectively and get rid from this disease as soon as possible.
Acomplia rimonabant weight loss drug is an oral-prescription medication which was approved in UK only as an appetite suppressant and still on waiting for FDA approval in USA. The works of acomplia rimonabant diet pill is simple to suppress appetite and hence loose weight. It works based on the simple principle of stimulating the hypothalamus gland, thereby influenci
Purchase Rimonabant Acomplia diet pill 2007-09-21 13:10:21 It looks like that FDA is not in rush at all. Rimonabant acomplia has been approved for sale in Mexico since Nov. 9th. after couple of EU states /like UK/ this drug finally arrived to America. This diet pill is still not a available in all Mexican pharmacies. So highly anticipated diet drug even after two months of approval is not on the sale.
The impending sale of Acomplia in Mexico is clearly of interest to a number of potential American customers, who have decided they want to take the diet pill even though the U.S. Food and Drug Administration is months away from action on approval of the drug for sale in the United States.
The Acomplia is the first selective CB1 receptor blocker and has been approved for use anywhere in the world except USA.
The Rimonabant acomplia is famous by blocking chemical processes directly in the brain,which cause reduce appetite, help liver to burn more fat and it might be effective drug to cure smoking and even alcohol abuse. This drug might bring a new Read more:Purchase
Truth About Acomplia Rimonabant Diet Pills 2007-09-21 13:09:02 A latest weight loss drug acomplia rimonabant is a true diet pills for treatment of obesity. Acomplia rimonabant diet pill is a weight loss and smoking cessation drugs which was approved in UK and Europe. For overweight patients, there are many solutions like dieting, fasting and exercise. But these solutions are difficult and not every obese person can do, so diet pills are best solution for weight loss. You may choose dieting to lose that extra pound of weight, unconscious of the fact that it makes you lose fat. Dieting is risky and makes you prone to perilous diseases. So, is there any other helpful option existing that can help you to loose weight? Yes, Acomplia rimonabant diet pills are the effective alternative for weight loss.
This statement stands true for people who want to bring about the unworkable. What all matters, is your approach towards life. The same applies to obese people, if you want to loose that extra weight then Acomplia rimonabant diet pills combined with health Read more:Truth
, Diet Pills
Acomplia information: Buy Rimonabant Online 2007-09-21 13:07:43 What is Acomplia? Acomplia is a weight loss medication which is developed by French drug maker. This weight loss medication works on the principle of an appetite suppressant. 20mg Acomplia is the customary dosage suggested for usage, which should be accompanied by a low calorific diet and regular workout regime. Expectant women, women planning pregnancy, breast-feeding mothers, children, diabetics, and heart patients are not recommended usage of film-coated Acomplia diet pill. Make sure that you pursue adequate precautionary measures while using Acomplia (Rimonabant) medication to prevent potential medical complications.
It is advisable to take each Acomplia dosage with a glassful of water. Make no attempt to overdose Acomplia medication as it can be damaging for your health. Individuals below the age group of 18 years of age are suggested usage of Acomplia diet pill.
In the 2years of clinical studies, Acomplia usage has also displayed other advantages besides weight loss. Other advant Read more:information
Rimonabant: Unsaddle The Burden Of Obesity 2007-09-19 15:19:14 Has excessive weight burdened your well-being too? Excessive weight can often be an indicator of obesity, well-denoted by BMI 30. Unsaddle your burden of obesity with Rimonabant (Acomplia) diet pill. Rimonabant can be simply understood as an effectual appetite suppressant which was unearthed and developed by French drug maker, Sanofi-Aventis. The goodness of Rimonabant can be enjoyed in the Sanofi Acomplia diet drug.
It works on the mechanism of obstructing the CB-1 receptors located in the Endo-cannabinoid (EC) system. These CB-1 receptors are responsible for regulating food consumption in the body. When these CB-1 receptors are obstructed it is consequential in reduction of your normal appetite. Reduction in normal appetite would indicate that you eat in smaller portions. In this way, you tend to lose weight.
In accordance to clinical trials 20mg Rimonabant is the suggested dosage which ought to be accompanied with a proper diet plan and regular diet regime. Each dose of Acomplia (Ri Read more:Burden
Rimonabant Diet Pill, Now Or Never 2007-09-19 15:17:44 Life seldom gives you opportunities. If taken on time, opportunities give maximum benefits. Whenever, opportunities are not utilised on right time, they become either non beneficial or partially beneficial. You are suffering from obesity and your obesity is in its initial phase. That means, you have body mass index between 27 and 30 or slightly over than 30. If your obesity is going through this phase, then you have an opportunity for weight loss. Opportunities rarely have any name, but this time there are two popular names for such an opportunity, Rimonabant or Acomplia.
Acomplia is the brand name of the medication while Rimonabant is the name of its active ingredient. Acomplia (Rimonabant), after its launch in the June 2006, has conquered a vast portion of weight loss drug market. This success of Rimonabant is the result of the benefits which it has given to numerous obese individuals in the European countries. After the UK, presently several other European countries are taking the b
Rimonabant: An Effective Weight Loss Drug 2007-09-29 17:31:52 This is for all obese people under the sun. Are you guys aware of the hazards you are loaded with just because of your body weight?
Some extra fat in your body can completely turn your life into a matter of disgust. You must become careful by now. Extra fat means high blood pressure, high sugar and above all unwanted rise in the level of cholesterol. And a combination of all these becomes heavy on your cardio-metabolic system. You become an acute patient of hypertension.
CB1 and body weight
Acomplia Rimonabant works exclusively to put down your body weight by allowing your cardio-metabolic system to function well. The direct association of this drug is with the CB1 factor in the human brain that plays a vital role in determining the body weight. Once a control over this CB1 factor is achieved you can easily regulate the weight.
Acomplia Rimonabant triggers inhibition in rise of the fat level and if the drug is consumed by maintaining a proper fitness schedule, it works better and faste Read more:Weight
Acomplia Launch: Sweden 2007-10-08 15:46:57 With obesity encircling us in its vicious ring, launch of Acomplia is definitely a respite to many obese worldwide. If you are an obese, then Acomplia is for you. Acomplia diet tablet with Rimonabant as its major constituent is developed by a French pharmaceutical form, Sanofi- Aventis. It is primarily an oral prescription medication to treat obesity. Since, its launch in the UK weight loss drug market, it has revolutionarised the weight loss scenario. Acomplia’s launch in Sweden
has added feather on the cap.
This wonder diet pill made its appearance in Sweden weight loss drug market on the November, 10th 2006. The good news tagged with its launch in Sweden is that the cost of Acomplia would be covered in for compensation. This decision was brought forward by the Sweden’s Pharmaceutical Benefits Board keeping in mind the benefits incurred by obese and overweight people facing health risks. Along with Sweden, Denmark and Ireland have also agreed upon reimbursing the cost of Acomplia Read more:Launch
Weight Loss Diet Pill Acomplia: Slimming Made Unproblematic 2007-10-08 15:42:38 An obese is a butt of jokes among his peers, which can tantalize him mentally. Besides this, an obese can be a prime target of health conditions such as high blood pressure, high cholesterol, diabetes which are among the other disadvantages tagged along with obesity. The unfortunate part is even the health insurers do not offer any coverage for obesity treatment, regardless of the serious health implications. What do you do?
Obesity can be measured by your BMI or Body Mass Index. If you have BMI or Body Mass Index equal to 30 or more, you come in the category of an obese. BMI is a calculated amount taking in account your height in proportion to your weight. BMI or Body Mass Index is a reliable indicator of your total body fat which is linked with disease or death.
Keeping the ill-effects of obesity in mind, it is essential to combat obesity. No one can help you to battle out obesity, unless you take an initiative. Acomplia drug (Rimonabant) can facilitate you in your endeavor of weigh Read more:Weight
, Weight Loss
Acomplia Pill: One More Point for Medical Science Progress 2007-10-08 15:37:44 Medical science has traveled a long distance in technological advancement. Particularly, last three decades have witnessed great changes in the technology related with diagnosis and treatment of diseases. No branch of medical science whether neurology or gastroenterology is left untouched of this technological revolution. Neurology is the system of coordination and control of body. Many efforts have been made to find out the relationship between ailments of body with neurological imbalance of the body. The results are wonderful; now many incurable diseases can be cured by proper stimulation of neurological system of the body. Obesity is one among such major diseases.
Obesity is the result of excessive intake of food which later is accumulated in the body beneath the skin in the form of fat, giving the body a bulky look. Our neurological system has a control over our dietary habits. Before eating anything we get permission from our brain. The brain permits us only when it will have the Read more:Science
Acomplia Sanofi Aventis: Messiah For The Obese 2007-10-08 15:34:20 Acomplia is a Sanofi Aventis creation, which is a large cap French pharmaceutical firm. Weight loss medication Acomplia is a product of two years of clinical trials undertaken in North America. Weight loss is not the only benefit which is sourced by use of this diet pill. Usage of this weight loss medication has also proven to be beneficial in improvement of cardio-metabolic risk factors, smoking cessation, and even minimization of chances of weight gain.
This weight loss medication has been in the news ever since its launch in the year 2006. At present, it is approved for sale in the UK, Switzerland, France, Germany, Ireland, Brazil, Mexico, and even UAE amid other countries.
Although it hasn’t yet received FDA approval for sale in the US but a trade name for its sale in the US Zimulti has already been decided. Sanofi Aventis is hopeful about its approval in the future, for which a fresh 50-month trials are already on their way, estimated to be completed in the year 2010. It seems t Read more:Messiah
, Obese
Rimonabant Acomplia: equals weight loss 2007-10-04 16:04:13 Keeping up with the calorie count can be quite a tiresome task. Fast paced life of the contemporary world, makes it even more difficult to maintain a healthy body. Irregular meals, dependence on junk food, lack of physical activity all contributes to those extra pounds.
Rimonabant is an anti-obesity drug, which was discovered and manufactured by Sanofi-Aventis, a French pharmaceutical company. It functions as an appetite suppressant. It works on the principle of targeting the CB-1 receptors, which are responsible for your appetite and nicotine intake. This in turn makes you eat less than your normal appetite, leading to weight loss.
It is an ideal solution for people who have BMI greater than 30. BMI refers to Body Mass Index, which is a calculated value of body weight in proportion to height. Rimonabant pill is like a magic potion, which can facilitate you to make an easy escape from the clutch of obesity and its consequent health problems.
Besides, serving as a weight loss pill it ca
Rimonabant is a Well Tolerated Antiobesity Diet Pill 2007-10-04 16:03:11 Weight gain is becoming a common problem throughout the world. People seem to be struggling with excessive weight gain problems. If you are one of them and finding some truly healthy weight loss solutions to shed out those stubborn fats from your body then you must know the fact that there is no short cut. The fact is that you have to change your life style with more physical activity and less crappy eating. But dieticians suggest that if a diet pill is added to this changed life style then the goal for weight loss is somewhat quickly achieved. Not surprisingly, the growing prevalence of obesity has stimulated the search for drugs like Rimonabant to fight against obesity.
Rimonabant is an anorectic anti-obesity drug. It works by suppressing our appetite making the stomach feel full. It is a cannabinoid receptor antagonist which blocks a special type of receptors called the CB1 receptors found in the nervous system. On the other hand, it is found that it also acts as smoking cessation a
Rimonabant The Agent for Treating Obesity 2007-10-04 16:01:57 Obesity is becoming the most common nutritional disorder in many industrialised country around the world. In countries like America and Europe it has reached epidemic levels. Furthermore, oflate there is an alarming rate of child obesity. This growing prevalence of obesity problem has stimulated the search of various anti obesity drugs. One such drug which is an outcome of such research is Rimonabant.
Generally know as Acomplia, Rimonabant is an appetite suppressant drug and is becoming a significant drug for the treatment of obesity. Though, marketed by Sanofi-Aventis, it is still waiting for FDA approval. But, it has been successful in gaining customer’s confidence and is creating a rage in the weight loss market.
It offers a unique therapeutic approach for controlling weight by suppressing the appetite. It works by blocking the CB1 receptors found in the endogenous cannabinoid system. Activation of these receptors increases the appetite. Clinically it has been found that Rimon Read more:Agent
Loose weight with acomplia rimonabant weight loss drug 2007-10-04 16:01:02 Acomplia Rimonabant diet pill is the most popular and successful weight loss drugs in United Kingdom that saved life of thousands of patients from a harmful and hazardous disease called obesity. Generally Acomplia Rimonabant is a CB1 blocker which offers solution to improve a variety of cardiometabolic risk factors in overweight and obese patients. These risk factors include hypertension,diabetes, high LDL cholesterol levels and other factors being investigated as insulin resistance, low HDL cholesterol, and high triglyceride levels.
This diet pills get good works when an obese patients do some exercise simultaneously with acomplia diet pill course. The CB1 receptors are found in the brain and in the peripheral organs and are part of the endocannabinoid system which is believed to play an important role in regulating body weight and controlling energy balance. So the works of acomplia diet pill is very easy and simple which helps in reducing body weight.
Generally obese people are very Read more:Loose
Buy Rimonabant and Kick out Obesity 2007-10-04 15:59:44 World’s most renowned health agency WHO after intense research revealed the following facts about obesity.
* More than 300 millions are suffering from obesity and about 1 billion people are over weight. * Obesity is increasing the risk of cardiovascular diseases and certain forms of cancer. * Increase in consumption of energy rich sugar and fat based food is making the situation worse.
Then the question arises. Why people are not trying to get rid of obesity if it is that much harmful? Answer is that people are trying to reduce obesity with their 100% efforts but unable to get rid of it. Lack of knowledge about how obesity affects their bodies is a major obstacle in their way.
Medical science differentiates human body in different systems namely skeleton system, transportation system, respiratory system, nervous system, digestive system, excretory system and reproduction system. Obesity is primarily related with digestive system and nervous system; any imbalance in these two ca
Recommend Site To A Friend
